The Statement addresses adults and children with the following conditions or undergoing the following procedures: Airflow obstruction including asthma and COPD. Bronchopulmonary dysplasia. Cystic fibrosis (CF). Non-CF bronchiectasis. Restrictive respiratory disease including interstitial lung disease (ILD), respiratory muscle and chest wall disorders. Thoracic surgery or other interventional procedures. Pleural disease including pneumothorax and pleural effusion. Respiratory infections. Obstructive sleep apnoea syndrome (OSAS) and obesity hypoventilation syndrome (OHS). Venous thromboembolism (VTE). Pulmonary hypertension (PH). Lung cancer and mesothelioma. Hyperventilation and dysfunctional breathing (DB).
No takes yet. Share an insight, caveat, or question.
Coker et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: